These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7174254)

  • 21. Controlling acid secretion: individual variation in response.
    Walt RP
    Br J Clin Pract Suppl; 1994; 75():9-12; discussion 13. PubMed ID: 8060804
    [No Abstract]   [Full Text] [Related]  

  • 22. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA
    Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical trial of Alcid V in peptic ulcer therapy].
    Vŭrbanov G; Rusinov E; Danev I; Glinkova V; Panecheva K
    Vutr Boles; 1981; 20(5):27-34. PubMed ID: 7034375
    [No Abstract]   [Full Text] [Related]  

  • 24. [Recent state of therapy of peptic disease].
    Pavlotzky M; Eshchar J
    Harefuah; 1985 Nov; 109(10):288-96. PubMed ID: 3912295
    [No Abstract]   [Full Text] [Related]  

  • 25. [Local factors in the pathogenesis of peptic ulcer].
    Grigor'ev PIa; Isakov VA; Iakovenko EP
    Klin Med (Mosk); 1988 May; 66(5):25-30. PubMed ID: 3047490
    [No Abstract]   [Full Text] [Related]  

  • 26. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Colloidal bismuth subcitrate (de-nol) in the treatment of peptic ulcer].
    Grigo'rev PIa; Isakov VA; Iakovenko EP
    Klin Med (Mosk); 1989 May; 67(5):17-22. PubMed ID: 2671482
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of modern anti-ulcer drugs.
    Garner A
    Br J Clin Pract Suppl; 1994; 75():1-5; discussion 6-8. PubMed ID: 7914740
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug therapy for peptic ulcer disease.
    Voirin J
    Am Fam Physician; 1984 Dec; 30(6):154-9. PubMed ID: 6095630
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of gastroduodenal ulcer with ulcosilvanil].
    Puşcaş I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(1):49-61. PubMed ID: 2884711
    [No Abstract]   [Full Text] [Related]  

  • 31. [Selective muscarinic receptor antagonists].
    Kishimoto S; Kajiyama G; Miyoshi A
    Nihon Rinsho; 1984 Jan; 42(1):114-9. PubMed ID: 6371305
    [No Abstract]   [Full Text] [Related]  

  • 32. Acid reduction or mucosal protection for peptic ulcer?
    Lancet; 1982 Aug; 2(8296):473-4. PubMed ID: 6125642
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessing the safety of drugs for the long-term treatment of peptic ulcers.
    Wormsley KG
    Gut; 1984 Dec; 25(12):1416-23. PubMed ID: 6150883
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of grandaxine in the treatment of patients with erosive-ulcerative stomach and gastroduodenal lesions].
    Vakhrushev IaM; Belova EV; Efremova LI
    Eksp Klin Gastroenterol; 2004; (4):21-4. PubMed ID: 15568662
    [No Abstract]   [Full Text] [Related]  

  • 35. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS; Shah AK; Bariwal J; Shelke SM; Kale AP; Jagtap JR; Bhosale AV
    Bioorg Med Chem; 2007 Feb; 15(3):1181-205. PubMed ID: 17150362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
    Gorshkov VA
    Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
    [No Abstract]   [Full Text] [Related]  

  • 37. De-Nol: mucosal protection and peptic ulcer disease. Proceedings of the De-Nol Symposium. September 8th, 1986, 8th World Congress of Gastroenterology, São Paulo.
    Digestion; 1987; 37 Suppl 2():1-64. PubMed ID: 3622944
    [No Abstract]   [Full Text] [Related]  

  • 38. Esaprazole effect on acid, peptic and alkaline secretion in duodenal ulcer patients.
    Dal Santo PL; Vianello F; Germana B; Dotto P; Laino G; Del Bianco T; Plebani M; Leandro G; Savarino V; Di Mario F
    Z Gastroenterol; 1993 Jan; 31(1):11-4. PubMed ID: 8447149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; mucosal blood-flow improving agents].
    Shimakura S; Fukutomi H
    Nihon Rinsho; 1988 Jan; 46(1):55-63. PubMed ID: 3373758
    [No Abstract]   [Full Text] [Related]  

  • 40. Proton pump inhibitors in the management of GORD and PUD.
    Kenny E
    Ir Med J; 1993; 86(4):114. PubMed ID: 8395486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.